What is the prevalence of sickle cell disease (SCD) in people of Mediterranean descent?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prevalence of Sickle Cell Disease in Mediterranean Populations

Sickle cell disease occurs in Mediterranean populations, though at lower rates than in African populations, with the condition affecting people from Mediterranean regions including Italy, Greece, and other Southern European countries. 1, 2

Geographic Distribution and Origin

  • Thalassemia major originated in Mediterranean, Middle Eastern, and Asian regions, while sickle cell disease originated from throughout central Africa. 1
  • However, due to migration patterns, both diseases now occur globally and represent a growing health problem in many countries. 1
  • SCD predominantly affects people of African or Caribbean background (98% in UK registry), but also occurs in families from the Middle East, India, and Mediterranean regions. 2

Specific Prevalence Data

While the evidence provided does not give exact prevalence rates for Mediterranean populations specifically, the following context is important:

  • The HbS mutation that causes sickle cell disease confers protection against malarial infection in heterozygous carriers, which led to high frequency of HbS in individuals of African and Mediterranean ancestry. 3
  • Variations in the G6PD gene (related to hemoglobinopathies) are found in high frequency in African as well as Mediterranean and Asiatic populations, with patterns consistent with recent positive selection due to malaria pressure. 1
  • In the European cohort of the CASiRe international study, 8% of SCD patients were Caucasian, including 21% of the Italian patients, demonstrating that Mediterranean Europeans do have SCD. 4

Clinical Implications

  • Mediterranean people with SCD are affected by the same disease manifestations as other populations, including painful vaso-occlusive crises, stroke risk, chronic hemolytic anemia, and progressive multi-organ damage. 2, 5
  • The genetic mutation is the same across populations—a C to A substitution at codon 6 of the beta globin gene, replacing glutamic acid with valine, creating abnormal hemoglobin S (HbS). 2

Important Caveats

  • The constantly growing incidence of sickle cell disease in Mediterranean areas is also caused by recent migrations, which has induced the World Health Organization to pressure national health systems to strengthen prevention programs. 6
  • Exact prevalence rates for Mediterranean populations are not well-documented in the literature, as most epidemiological studies focus on African and African-descended populations where the disease burden is highest. 5, 3

References

Related Questions

What are the steps to diagnose sickle cell disease?
Can a child inherit the gene for sickle cell anemia from just one parent or is it required from both parents?
What is the best next step in managing a patient with sickle cell disease presenting with dyspnea (shortness of breath) and pleuritic chest pain, hypoxia (low oxygen saturation), and a right lower lobe infiltrate on chest X-ray?
What are the recommended antipyretics (fever reducers) for patients with sickle cell disease?
What is the best antacid for a patient with sickle cell disease?
What is the initial medical management for a hemodynamically stable patient with an ectopic pregnancy?
What is the best treatment approach for a patient presenting with hypertensive urgency?
What is the best course of treatment for a 6-month postpartum woman with a recent onset of neuropathic symptoms, including pain and buzzing sensations, and a positive Antinuclear Antibody (ANA) result, that started at 5 months postpartum?
What are the symptoms and treatment options for hypothermia, particularly in patients with underlying medical conditions such as diabetes or cardiovascular disease?
What is the recommended treatment for a patient with hypothyroidism, specifically for those with a history of non-papillary (NP) thyroid cancer, and how should their thyroid-stimulating hormone (TSH) levels be managed?
What is the recommended treatment for a patient with pneumonia, considering age and potential underlying conditions such as Chronic Obstructive Pulmonary Disease (COPD) or asthma?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.